About

Substantial progress in the treatment of atherosclerotic complications – in particular in secondary prevention – has led to a significant reduction of recurrent cardiovascular events. This has been through the use of pharmacological strategies including lipid-lowering drugs such as statins, beta-blockers, angiotensin-converting ensyme inhibitors and angiotensin receptor blockers, along with the introduction of early percutaneous coronary intervention in acute coronary syndrome with consecutive application of dual antiplatelet therapy.

Articles

Atherosclerosis Plaque Imaging and Characterization Using Magnetic Resonance Imaging

Homocysteine-lowering Treatment in Reduction of Stroke and Coronary Vascular Risk - Do Not Give Up

Citation:

US Cardiology 2009;6(1):36–40

Effects of Reconstituted High-density Lipoprotein Infusions on Coronary Atherosclerosis

Citation:

US Cardiology 2007;4(2):32–4

Atherosclerotic Plaque Characterization from Radio Frequency Ultrasound Signal Processing

Citation:

US Cardiology 2007;4(1):54–6